More than four million Spaniards suffer migrainewhich represents 12% of the population. 80% of them are women, especially between 20 and 40 years old.
Although it is a pathology with a significant incidence, almost 54% of these patients indicate that they have not found a solution to cope with the symptoms of the disease.
In our country it is already available Vydura (rimegepant), the first treatment to prevent and treat migraine attacks, which provides freedom from pain and the most annoying symptom two hours following receiving this medication, marketed by the pharmaceutical company Pfizer. The relief of symptoms can last up to 48 hours.
Vydura contains the active ingredient rimegepant, It slows down the activity of a substance in the body called calcitonin gene-related peptide (CGRP). People with migraines may have elevated levels of CGRP. Rimegepant binds to the CGRP receptor, reducing the ability of CGRP to also bind to the receptor. This reduces the activity of CGRP and produces two effects: it can stop an active migraine attack, and can reduce the number of migraine attacks that occur when taken preventively.
Vydura It is used to treat and prevent seizures of migraine in adults. For the prevention of migraine, The recommended dose is an oral lyophilisate (75 mg rimegepant) every other day.
For the treatment of a migraine attack once it has started, The recommended dose is an oral lyophilisate (75 mg of rimegepant) as needed, no more than once a day.
The maximum daily dose is a lyophilized oral (75 mg rimegepant) daily.
How to take this medicine
Vydura is administered orally. The oral lyophilisate can be taken with or without food or water.
Like all medications, this medication can produce adverse effects, although not all people suffer from them.
Stop using Vydura and contact your doctor immediately if you have signs of an allergic reaction. such as severe skin rash or difficulty breathing. Allergic reactions with Vydura are rare (may affect up to 1 in 100 people).
A common side effect (may affect up to 1 in 10 people) is nausea.
Patients suffering from migraine They can access the medicine in pharmacies, but at its market price (29 euros per tablet) and always with a prescription.
